---
document_datetime: 2023-10-31 11:10:18
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/levetiracetam-sun-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: levetiracetam-sun-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.1169562
conversion_datetime: 2025-12-27 14:24:59.308533
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Levetiracetam SUN

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                    | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0030              | B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product | 19/09/2023                          |                                             | SmPC, Labelling and PL           |           |
| IB/0029/G            | This was an application for a group of variations.                                                                       | 16/08/2023                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|         | in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |            |             | C.I.2.a - Change   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------|
| IB/0028 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                               | 23/06/2022 | 26/05/2023 | SmPC and PL |                    |
| IA/0027 | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                                                                                 | 05/04/2022 | n/a        |             |                    |
| II/0026 | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                | 16/12/2021 | n/a        |             |                    |
| IB/0025 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO                                                                                                                                                                                                                                                                                                          | 19/05/2021 | 04/06/2021 | SmPC and PL |                    |

<div style=\"page-break-after: always\"></div>

|           | additional data is required to be submitted by MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            |                        | new the   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------|
| IAIN/0024 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 27/01/2021 | n/a        |                        |           |
| IB/0023/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 19/01/2021 | 18/03/2021 | SmPC, Labelling and PL | the MAH   |
| N/0022    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 02/10/2020 | 18/03/2021 | PL                     |           |
| IAIN/0021 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 29/06/2020 | n/a        |                        |           |
| IB/0020   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 12/03/2020 | 18/03/2021 | SmPC and PL            |           |

<div style=\"page-break-after: always\"></div>

|           | of the same change for the reference - Implementation of change(s) for which NO additional data is required to be submitted by MAH                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |                                  | assessment product new the   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------|
| IB/0019   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                 | 12/09/2019 | 24/10/2019 | SmPC, Annex II, Labelling and PL |                              |
| IA/0018   | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                            | 13/08/2019 | n/a        |                                  |                              |
| IB/0017/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 26/10/2018 | 24/10/2019 | SmPC and PL                      |                              |

<div style=\"page-break-after: always\"></div>

| N/0016   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 24/07/2018   | 24/10/2019   | PL                     |                                                                                                                                                                                                                                                                                 |
|----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0015   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 28/11/2017   | 20/12/2017   | PL                     |                                                                                                                                                                                                                                                                                 |
| IB/0014  | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 23/01/2017   | 20/12/2017   | SmPC and PL            |                                                                                                                                                                                                                                                                                 |
| R/0013   | Renewal of the marketing authorisation.                                                                                                                                                                                                                      | 15/09/2016   | 14/11/2016   | Annex II and PL        | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Levetiracetam SUN in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IB/0012  | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 06/04/2016   | 14/11/2016   | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                 |
| IA/0011  | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                 | 27/01/2016   | n/a          |                        |                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| IAIN/0010   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                    | 28/10/2015   | n/a        |                       |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------|
| II/0008     | B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                                                                                                                                                                                                                                                                                                                                                 | 22/10/2015   | n/a        |                       |
| IB/0009/G   | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition | 03/06/2015   | n/a        |                       |
| IB/0007/G   | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following                                                                                                                                                                                                                                                                                                                                                                                                                                  | 28/03/2014   | 06/02/2015 | SmPC, Annex II and PL |

<div style=\"page-break-after: always\"></div>

|           | change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |            |             | assessment of the same   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------|
| IB/0006   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                             | 14/02/2014 | 06/02/2015 | SmPC        |                          |
| IAIN/0005 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                       | 21/11/2013 | n/a        |             |                          |
| IB/0004   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                          | 20/11/2013 | 18/12/2013 | SmPC and PL |                          |
| N/0003    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                      | 20/03/2013 | 18/12/2013 | PL          |                          |
| IA/0002   | B.II.e.7.b - Change in supplier of packaging                                                                                                                                                                                                                                                                                                                                                          | 16/01/2013 | 18/12/2013 | SmPC        |                          |

<div style=\"page-break-after: always\"></div>

|         | components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                  |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0001 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 12/07/2012 | 31/10/2012 | SmPC, Labelling and PL | Update of SmPC section 4.8 to bring it in line with SmPC for the originator in order to add 'panic attack' as an undesirable effect following the cumulative review of the safety data for Keppra as requested by CHMP. In addition, editorial changes were made to sections 2 and 4.4 in order to change the description of the quantity of the sodium excipient in Levetiracetam SUN concentrate for solution for infusion. Sections 8, 9 and 10 of the SmPC were also updated. The Package Leaflet was updated in accordance. Editorial changes were also made to Annex IIIA. Moreover, the description of pancytopenia, erythema multiforme, Stevens-Johnsons syndrome and toxic epidermal necrolysis in section 4 of the Package Leaflet was added together with an update of local representatives. Furthermore, the PI is brought in line with the latest QRD template, version 8. |